Literature DB >> 19151751

p120Ras-GAP binds the DLC1 Rho-GAP tumor suppressor protein and inhibits its RhoA GTPase and growth-suppressing activities.

X-Y Yang1, M Guan, D Vigil, C J Der, D R Lowy, N C Popescu.   

Abstract

DLC1 (deleted in liver cancer 1), which encodes a Rho GTPase-activating protein (Rho-GAP), is a potent tumor suppressor gene that is frequently inactivated in several human cancers. DLC1 is a multidomain protein that has been shown previously to bind members of the tensin gene family. Here we show that p120Ras-GAP (Ras-GAP; also known as RASA1) interacts and extensively colocalizes with DLC1 in focal adhesions. The binding was mapped to the SH3 domain located in the N terminus of Ras-GAP and to the Rho-GAP catalytic domain located in the C terminus of the DLC1. In vitro analyses with purified proteins determined that the isolated Ras-GAP SH3 domain inhibits DLC1 Rho-GAP activity, suggesting that Ras-GAP is a negative regulator of DLC1 Rho-GAP activity. Consistent with this possibility, we found that ectopic overexpression of Ras-GAP in a Ras-GAP-insensitive tumor line impaired the growth-suppressing activity of DLC1 and increased RhoA activity in vivo. Our observations expand the complexity of proteins that regulate DLC1 function and define a novel mechanism of the cross talk between Ras and Rho GTPases.1R01CA129610

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19151751      PMCID: PMC2715999          DOI: 10.1038/onc.2008.498

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  48 in total

1.  Identification of Aurora kinases as RasGAP Src homology 3 domain-binding proteins.

Authors:  Veronique Gigoux; Sebastien L'Hoste; Francoise Raynaud; Jacques Camonis; Christiane Garbay
Journal:  J Biol Chem       Date:  2002-04-25       Impact factor: 5.157

Review 2.  Molecular recognition by SH2 domains.

Authors:  J Michael Bradshaw; Gabriel Waksman
Journal:  Adv Protein Chem       Date:  2002

3.  Characterization of G3BPs: tissue specific expression, chromosomal localisation and rasGAP(120) binding studies.

Authors:  D Kennedy; J French; E Guitard; K Ru; B Tocque; J Mattick
Journal:  J Cell Biochem       Date:  2001       Impact factor: 4.429

4.  Mutations in the focal adhesion targeting region of deleted in liver cancer-1 attenuate their expression and function.

Authors:  Yi-Chun Liao; Yi-Ping Shih; Su Hao Lo
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

5.  Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.

Authors:  M Guan; V Tripathi; X Zhou; N C Popescu
Journal:  Cancer Gene Ther       Date:  2008-03-28       Impact factor: 5.987

6.  DLC1 suppresses distant dissemination of human hepatocellular carcinoma cells in nude mice through reduction of RhoA GTPase activity, actin cytoskeletal disruption and down-regulation of genes involved in metastasis.

Authors:  Xiaoling Zhou; Drazen B Zimonjic; Sang-Won Park; Xu-Yu Yang; Marian E Durkin; Nicholas C Popescu
Journal:  Int J Oncol       Date:  2008-06       Impact factor: 5.650

7.  Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.

Authors:  Siân Jones; Xiaosong Zhang; D Williams Parsons; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; Hirohiko Kamiyama; Antonio Jimeno; Seung-Mo Hong; Baojin Fu; Ming-Tseh Lin; Eric S Calhoun; Mihoko Kamiyama; Kimberly Walter; Tatiana Nikolskaya; Yuri Nikolsky; James Hartigan; Douglas R Smith; Manuel Hidalgo; Steven D Leach; Alison P Klein; Elizabeth M Jaffee; Michael Goggins; Anirban Maitra; Christine Iacobuzio-Donahue; James R Eshleman; Scott E Kern; Ralph H Hruban; Rachel Karchin; Nickolas Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

8.  The adhesion signaling molecule p190 RhoGAP is required for morphogenetic processes in neural development.

Authors:  M R Brouns; S F Matheson; K Q Hu; I Delalle; V S Caviness; J Silver; R T Bronson; J Settleman
Journal:  Development       Date:  2000-11       Impact factor: 6.868

9.  A RasGAP SH3 peptide aptamer inhibits RasGAP-Aurora interaction and induces caspase-independent tumor cell death.

Authors:  Perayot Pamonsinlapatham; Réda Hadj-Slimane; Françoise Raynaud; Marc Bickle; Claudine Corneloup; Audrey Barthelaix; Yves Lepelletier; Perrine Mercier; Matthieu Schapira; Jérôme Samson; Anne-Laure Mathieu; Nicolas Hugo; Olivier Moncorgé; Ivan Mikaelian; Sylvie Dufour; Christiane Garbay; Pierre Colas
Journal:  PLoS One       Date:  2008-08-06       Impact factor: 3.240

10.  Effects of structure of Rho GTPase-activating protein DLC-1 on cell morphology and migration.

Authors:  Tai Young Kim; Kevin D Healy; Channing J Der; Noah Sciaky; Yung-Jue Bang; Rudy L Juliano
Journal:  J Biol Chem       Date:  2008-09-11       Impact factor: 5.157

View more
  33 in total

1.  Cell proliferation and oxidative stress pathways are modified in fibroblasts from Sturge-Weber syndrome patients.

Authors:  Shilpa D Kadam; Marjan Gucek; Robert N Cole; Paul A Watkins; Anne M Comi
Journal:  Arch Dermatol Res       Date:  2012-03-10       Impact factor: 3.017

2.  DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism.

Authors:  Xuyu Yang; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Cancer Res       Date:  2011-03-03       Impact factor: 12.701

3.  Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.

Authors:  Xiaoling Zhou; Xu-Yu Yang; Nicholas C Popescu
Journal:  Biochem Biophys Res Commun       Date:  2012-03-07       Impact factor: 3.575

4.  DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity.

Authors:  Veenu Tripathi; Nicholas C Popescu; Drazen B Zimonjic
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

5.  Deciphering the Molecular and Functional Basis of RHOGAP Family Proteins: A SYSTEMATIC APPROACH TOWARD SELECTIVE INACTIVATION OF RHO FAMILY PROTEINS.

Authors:  Ehsan Amin; Mamta Jaiswal; Urszula Derewenda; Katarina Reis; Kazem Nouri; Katja T Koessmeier; Pontus Aspenström; Avril V Somlyo; Radovan Dvorsky; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2016-08-01       Impact factor: 5.157

6.  Functional cross-talk between ras and rho pathways: a Ras-specific GTPase-activating protein (p120RasGAP) competitively inhibits the RhoGAP activity of deleted in liver cancer (DLC) tumor suppressor by masking the catalytic arginine finger.

Authors:  Mamta Jaiswal; Radovan Dvorsky; Ehsan Amin; Sarah L Risse; Eyad K Fansa; Si-Cai Zhang; Mohamed S Taha; Aziz R Gauhar; Saeideh Nakhaei-Rad; Claus Kordes; Katja T Koessmeier; Ion C Cirstea; Monilola A Olayioye; Dieter Häussinger; Mohammad R Ahmadian
Journal:  J Biol Chem       Date:  2014-01-17       Impact factor: 5.157

7.  Full activity of the deleted in liver cancer 1 (DLC1) tumor suppressor depends on an LD-like motif that binds talin and focal adhesion kinase (FAK).

Authors:  Guorong Li; Xiaoli Du; William C Vass; Alex G Papageorge; Douglas R Lowy; Xiaolan Qian
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

8.  RASAL2 activates RAC1 to promote triple-negative breast cancer progression.

Authors:  Min Feng; Yi Bao; Zhimei Li; Juntao Li; Min Gong; Stella Lam; Jinhua Wang; Diego M Marzese; Nicholas Donovan; Ern Yu Tan; Dave S B Hoon; Qiang Yu
Journal:  J Clin Invest       Date:  2014-11-10       Impact factor: 14.808

Review 9.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

10.  DLC1 activation requires lipid interaction through a polybasic region preceding the RhoGAP domain.

Authors:  Patrik Erlmann; Simone Schmid; Florian A Horenkamp; Matthias Geyer; Thomas G Pomorski; Monilola A Olayioye
Journal:  Mol Biol Cell       Date:  2009-08-26       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.